A new study commissioned by AbbVie and prepared by HTANALYSTS has found that people on the ‘front line’ of caring for someone with advanced Parkinson’s disease secure the most significant gains when patients living with the condition can access standard-of-care treatments. …
Australian study finds families gain the most with treatment of advanced Parkinson’s disease
March 20, 2024 Latest NewsBioPharma
Latest Video
New Stories
-
The private market might do what two decades of PBS reform attempts couldn't
October 12, 2026 - - Latest News -
The full set of numbers tell the story and reveal the massive funding shortfall
October 12, 2026 - - Latest News -
Private prescription market heads towards $4 billion as PBS spending stalls
October 12, 2026 - - Latest News -
The 'Dispatched' Podcast Week in Review - Series 5. Ep.35
October 9, 2026 - - Podcast -
PhRMA goes to court over price rule that uses Australia as a benchmark
October 9, 2026 - - Latest News -
A tale of two systems with billions shifting to the private market
October 9, 2026 - - Latest News -
GLP-1s are quickly reshaping the Australian prescription medicines market
October 9, 2026 - - Latest News